Table 1.
Descriptive and statistical overview of patients’ sociodemographic dimensions and medication at baseline, separately by group (intervention versus control condition)
| N | Group
|
Statistics | |
|---|---|---|---|
| Intervention group
|
Control group
|
||
| 20 | 20 | ||
| Age, years (standard deviation) | 32.07 (5.76) | 31.21 (6.10) | t(38)=0.38, P>0.78 |
| Sex (male/female) | 5/15 | 7/13 | χ2(df=1, N=40) =0.85, P>0.35 |
| Civil status (single/married) | 6/14 | 7/13 | χ2(1) =0.19, P>0.65 |
| Medications | |||
| Benzodiazepines (yes/no) | 12/8 | 10/10 | χ2(1) <1.5, P>0.1 |
| Antidepressants (yes/no) | 18/2 | 16/4 | χ2(1) <1.5, P>0.1 |
| Neuroleptics (yes/no) | 6/14 | 9/11 | χ2(1) <1.5, P>0.1 |
| Patients receiving one pharmacologic agent (yes/no) | 20/0 | 20/0 | – |
| Patients receiving two pharmacologic agents | 9/11 | 11/9 | χ2(1) <1.0, P>0.1 |
| Patients receiving three or more pharmacologic agents | 3/17 | 2/18 | χ2(1) <1.0, P>0.1 |